NYSE:JNJ
Johnson & Johnson Stock News
$149.91
+0.0600 (+0.0400%)
At Close: May 10, 2024
Paediatric Epilepsy Therapeutics Market Focusing on Current Trends, Leading with Top Key Players like Abbott., GlaxoSmithKline plc., Cephalon, Inc., Johnson & Johnson
05:25pm, Wednesday, 17'th Nov 2021 OpenPR
DBMR has added a new report titled Paediatric Epilepsy Therapeutics Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. The credible report comprises of the market
Johnson and Johnsons new vaccines leader talks Covid-19, pipeline plans, and a golden opportunity for clinical trials
02:30pm, Wednesday, 17'th Nov 2021 STAT News
Theres a changing of the guard at Janssen, Johnson & Johnsons vaccines division. In June, the company announced that Penny Heaton, formerly the founding CEO of the Bill and Melinda
Arrowhead Announces JNJ-75220795 in Development for NASH
02:00pm, Wednesday, 17'th Nov 2021 Arrowhead Pharmaceuticals
PASADENA, Calif. --(BUSINESS WIRE)--Nov. 17, 2021-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that its collaborator, Janssen Pharmaceuticals, Inc. , (Janssen) one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has disclosed its collaboration with Arrowhead on
Breast Implant Market Size, Share & Growth Analysis To 2027|Allergan, Mentor Worldwide (Johnson & Johnson), GC Aesthetics
12:13pm, Wednesday, 17'th Nov 2021 OpenPR
The global Breast Implant market was valued at 132.33 Million USD in 2020 and will grow with a CAGR of 8.84% from 2021 to 2027. Breast augmentation is a surgical procedure used to augment the breast size and improve certain
Ophthalmology Device Market Regional Growth Drivers, Opportunities and Trends 2021-2027|Alcon, Bausch + Lomb, Carl Zeiss Meditec, Johnson & Johnson
12:12pm, Wednesday, 17'th Nov 2021 OpenPR
The global Ophthalmology Devices market was valued at 4027.09 Million USD in 2020 and will grow with a CAGR of 2.9% from 2021 to 2027. Ophthalmology is known to be a field of medical science that handles with the function,
Businessinsider.co.za | New site connects SA health workers with booster jabs and will roll out to the public
10:25am, Wednesday, 17'th Nov 2021 Business Insider South Africa
A new online platform connects healthcare workers with their nearest vaccination sites offering Johnson & Johnson jabs.
Global Psoriasis Treatment Market Size 2020-2027 | North America, Europe, Asia-Pacific & Latin America Forecast Report
08:48am, Wednesday, 17'th Nov 2021 Intrado Digital Media
List of Companies profiled in the Report: AbbVie Inc. (Illinois, United States), Novartis AG (Basel, Switzerland), Johnson & Johnson Services, Inc. (New Jersey, United States), Pfizer Inc., (New York, United States), LEO Pharma A/S (Ballerup, Denmark), Merck & Co., Inc. (New Jersey, United States), Amgen Inc. (California, United States), Eli Lilly and Company (Indiana, United States), CELGENE CORPORATION (New Jersey, United States), UCB S.A. (Brussels, Belgium), Sun Pharmaceutical Industries Ltd. (Mumbai, India), Other prominent players List of Companies profiled in the Report: AbbVie Inc. (Illinois, United States), Novartis AG (Basel, Switzerland), Johnson & Johnson Services, Inc. (New Jersey, United States), Pfizer Inc., (New York, United States), LEO Pharma A/S (Ballerup, Denmark), Merck & Co., Inc. (New Jersey, United States), Amgen Inc. (California, United States), Eli Lilly and Company (Indiana, United States), CELGENE CORPORATION (New Jersey, United States), UCB S.A. (Brussels, Belgium), Sun Pharmaceutical Industries Ltd.
COVID-19 booster shots are a bit of a distraction, expert says
03:30am, Wednesday, 17'th Nov 2021 Deseret
Davis County community health nurse Bruno Gonzalez prepares a Johnson & Johnson COVID-19 booster vaccine at the Legacy Events Center in Farmington on Monday, Oct. 25, 2021. | Kristin Murphy, Deseret News The government continues to promote COVID-19 booster shots, even though millions remain unvaccinated The United States might be focusing on the wrong target when it comes to COVID-19, according to Dr. Anand Swaminathan , a New Jersey-based emergency medicine physician. Swaminathan recently told Yahoo! Finance that the United States has shifted heavily toward promoting booster shots instead of first doses. Honestly, I think that boosters right now are a bit of a distraction away from where we should be focused, which is getting first doses, especially since we know that even now, even with Delta surging, the primary doses of the vaccines are highly protective against serious infection, against hospitalization, Swaminathan said. Swaminathan added that the booster shots are a temporary measure to improve antibodies and immunity against COVID-19.
Bar Harbor Trust Services Buys PACCAR Inc, Oracle Corp, Freeport-McMoRan Inc, Sells ...
01:38am, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: JNJ , BKR , ROK , VO , ELS , KMI , PCAR , ORCL , FCX , QUAL , RNR , IBM , MDY ,
Pfizer, BioNTech, Moderna making $1,000 profit every second
11:22pm, Tuesday, 16'th Nov 2021 Business Recorder
WASHINGTON: Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the worlds poorest countries remain largely unvaccinated, according to a new analysis. The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the Peoples Vaccine Alliance (PVA), a coalition campaigning for wider access to Covid vaccines, which based its calculations on the firms own earning reports. The Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a second, $65,000 a minute or $93.5 million a day. It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus, Maaza Seyoum of the African Alliance and Peoples Vaccine Alliance Africa said. Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low-income countries out in the cold. Pfizer and BioNTech have delivered less than one percent of their total supplies to low-income countries while Moderna has delivered just 0.2 percent, the PVA said.
First Fiduciary Investment Counsel Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
11:08pm, Tuesday, 16'th Nov 2021 Dakota Financial News
First Fiduciary Investment Counsel Inc. cut its holdings in Johnson & Johnson (NYSE:JNJ) by 3.1% during the third quarter, Holdings Channel.com reports. The fund owned 103,419 shares of the companys stock after selling 3,331 shares during the period. Johnson & Johnson comprises about 3.3% of First Fiduciary Investment Counsel Inc.s holdings, making the stock its []
Carroll Financial Associates Inc. Acquires 283 Shares of Johnson & Johnson (NYSE:JNJ)
10:32pm, Tuesday, 16'th Nov 2021 Dakota Financial News
Carroll Financial Associates Inc. boosted its holdings in Johnson & Johnson (NYSE:JNJ) by 0.5% during the third quarter, HoldingsChannel.com reports. The fund owned 57,791 shares of the companys stock after purchasing an additional 283 shares during the period. Carroll Financial Associates Inc.s holdings in Johnson & Johnson were worth $9,333,000 at the end of the []
Sask. acquires Johnson & Johnson COVID-19 doses for unvaxxed residents
07:33pm, Tuesday, 16'th Nov 2021 SaskToday Canada
Saskatchewan has received a limited amount of one-dose Johnson & Johnson vaccines for residents who have yet to be immunized.
Endurant Capital Management LP Buys Humana Inc, Johnson & Johnson, AbbVie Inc, Sells Thermo ...
06:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: HUM , JNJ , ABBV , SIBN , HOLX , BMY , MCK , ATR , AHCO , PKI , BDX , SNY , TMO , HAE , EAR , TRIL , ANTM , FATE ,
Single-dose Johnson & Johnson vaccine available in Sask. beginning Wednesday
06:18pm, Tuesday, 16'th Nov 2021 Global News Canada
The Saskatchewan government announced Tuesday that a supply of the one-dose J&J COVID-19 shot will be administered through multiple SHA clinics on a first-come, first-serve basis.